The number of opioid prescriptions decreased 33% nationally from 2013 to 2018, according to the new report from the American Medical Association...
Data support the hypothesis that hepatitis C virus infection is a risk factor for incident Parkinson’s disease.
News from the FDA/CDC
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.
SAN DIEGO – In the absence of randomized trial evidence, a PPI prescribing approach based on appropriate use appears sufficient.
SEATTLE – First-dose cardiac events with fingolimod are rare, regardless of whether first-dose observations occur in clinic or at home.
SAN FRANCISCO – It’s best to ask people what they’re using, and to counsel new users – especially the elderly – to start low and go slow, Dr....
SEATTLE – But it is not clear if there is a cause-and-effect relationship.
SEATTLE – Trials vary widely in quality, review finds, and most focused on Sativex.
SEATTLE – In a novel study, about half of patients with multiple sclerosis reported clinically significant symptoms of depression or pain, and...
SEATTLE – Few studies have examined the relationships between physical activity, sedentary behavior, and sleep...